Eradivir Funding & Investors
West Lafayette, IN
Eradivir is a biotech company that aims to develop a non-immunological targeting agent for use against the virus that causes COVID-19.
eradivir.comTotal Amount Raised: $22,056,000
Eradivir Funding Rounds
Undisclosed
$10,000,000
Series A
$10,800,000
Series A Investors
Philip LowGrant
$1,000,000
Grant Investors
National Science FoundationBARDAGrant
$256,000
Grant Investors
National Science Foundation
Funding info provided by Diffbot.